Drug intelligence / Profile preview

DGAT1 shRNA

Development stage
Preclinical
Lead developer
부산대학교
Modality
Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies, RNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

DGAT1 shRNA is a short hairpin RNA (shRNA) designed to silence the expression of diacylglycerol acyltransferase 1 (DGAT1). DGAT1 is an enzyme that catalyzes the final step of triglyceride synthesis by converting diacylglycerol (DAG) to triglycerides. In the context of glioblastoma (GBM), research has shown that radioresistant GBM cells upregulate DGAT1 to maintain lipid homeostasis and evade mitochondrial lipotoxicity. By knocking down DGAT1, this shRNA reduces lipid droplet formation and sensitizes GBM cells to ionizing radiation, both in vitro and in vivo. This suggests that targeting the DGKB-DGAT1 axis is a potential therapeutic strategy for overcoming radioresistance in GBM.

Other names
sh-DGAT1sh-DGAT-1sh-DGAT 1DGAT1 short hairpin RNADGAT-1 short hairpin RNADGAT 1 short hairpin RNA
02

Targets

DGAT1 (Diacylglycerol O-acyltransferase 1)

Beyond the preview

Go deeper on DGAT1 shRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DGAT1 shRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call